SomniProbe Model Number 10093 Modification
510(k) K912234
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK912234 | Date22 Jul 1991 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Somniprobe(R) Model Number 10093, Modification
- 510(k) Number
- FDA Product Code
- BZG
- Device Class
- Class II
- Regulation
- 21 CFR Part 868.1840
- Advisory Committee
- Anesthesiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 20 Sep 2026
The SomniProbe Model Number 10093 Modification is a diagnostic device classified as a spirometer, designed for measuring airflow during respiratory studies. It is intended for monitoring nasal and buccal airflow, aiding in the assessment of sleep-related breathing disorders such as sleep apnea and other respiratory conditions.
This device is supplied as a reusable medical instrument and is cleared for use in clinical settings under FDA 510(k) authorization (K912234). It falls under the regulatory category of Class II devices (regulation number 868.1840) and is intended for use in anesthesiology. No specific sterility or MRI safety information is provided in the available data.
Other devices from Somnitec, Inc.
Questions
AI-generated answers, 20 Sep 2026
What clinical conditions is the SomniProbe Model 10093 Modification primarily used to evaluate?
The SomniProbe Model 10093 Modification is designed to measure airflow during respiratory studies, specifically for assessing nasal and buccal airflow. This aids in diagnosing and evaluating sleep-related breathing disorders, such as sleep apnea, as well as other respiratory conditions that may impact airflow during sleep or anesthesia.
Is the SomniProbe Model 10093 Modification intended for single-use or reusable applications in clinical settings?
The SomniProbe Model 10093 Modification is explicitly described as a reusable medical instrument, meaning it is intended for repeated use in clinical environments after proper cleaning and maintenance. No information regarding single-use or disposable variants is provided in the available data.
What regulatory pathway was followed for FDA clearance of the SomniProbe Model 10093 Modification?
The SomniProbe Model 10093 Modification was cleared through the FDA 510(k) pathway under the classification of a Class II device (regulation number 868.1840). The submission was reviewed by the Anesthesiology (AN) Advisory Committee and determined to be substantially equivalent to a predicate device, with a traditional clearance type (K912234).
Are there any specific sterility requirements or MRI safety considerations mentioned for the SomniProbe Model 10093 Modification?
The provided data does not include any details regarding sterility requirements or MRI safety for the SomniProbe Model 10093 Modification. Users should follow standard clinical protocols for cleaning, disinfection, and handling reusable medical devices, and consult manufacturer guidelines for MRI compatibility if needed.
What medical specialty is the SomniProbe Model 10093 Modification primarily associated with, and how does this relate to its intended use?
The SomniProbe Model 10093 Modification is primarily associated with anesthesiology, as indicated by its regulatory classification and advisory committee review. While it functions as a spirometer for measuring airflow, its intended use in this specialty likely relates to preoperative respiratory assessments, intraoperative monitoring, or postoperative evaluations where airflow dynamics are critical, such as in patients with suspected sleep apnea or other respiratory conditions.